Effects of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function in Patients with Chronic Heart Failure
ESC Heart Failure2021Vol. 8(6), pp. 5327–5337
Citations Over TimeTop 10% of 2021 papers
Julie Kolwelter, Agnes Bosch, Susanne Jung, Lena Stabel, Dennis Kannenkeril, Christian Ott, Peter Bramlage, Mario Schiffer, Stephan Achenbach, Roland E. Schmieder
Abstract
We found an improvement of vascular function after treatment with empagliflozin that indicates decreased afterload of the left ventricle and may contribute to the beneficial effects of SGLT2 inhibition in HF.
Related Papers
- Коммуникaтивно- прaгмaтический aнaлиз дипломaтических бумaг (нa основе вербaльных нот)(2018)
- FEATURES AND DIFFERENCES OF ADEQUATE AND EQUIVALENT TRANSLATION(2018)
- चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ à¤à¥Œà¤—ोलिक अधà¥à¤¯à¤¯à¤¨ )(2017)
- → ФОРМИРОВAНИЕ ГОТОВНОСТИ БУДУЩИХ ПЕДAГОГОВ К ОРГAНИЗAЦИИ РAБОТЫ ПО РAЗВИТИЮ ВAЛЕОЛОГИЧЕСКОЙ КУЛЬТУРЫ ШКОЛЬНИКОВ(2023)